dc.contributor.author | Pauwels, Patrick | |
dc.contributor.author | Penault-Llorca, Frederique | |
dc.contributor.author | Almarez, Todd | |
dc.contributor.author | Wu, Meijing | |
dc.contributor.author | Hader, Carlos | |
dc.contributor.author | Miljkovic, Darko | |
dc.contributor.author | Gosney, John | |
dc.contributor.author | Biesma, Bonne | |
dc.contributor.author | Brcic, Luka | |
dc.contributor.author | Sailer, Verena | |
dc.contributor.author | Rojo, Federico | |
dc.contributor.author | Corassa, Marcelo | |
dc.contributor.author | Mavroudis, Dimitrios | |
dc.contributor.author | Oz, Aysim Buge | |
dc.date.accessioned | 2021-03-02T17:18:58Z | |
dc.date.available | 2021-03-02T17:18:58Z | |
dc.identifier.citation | Rojo F., Corassa M., Mavroudis D., Oz A. B. , Biesma B., Brcic L., Pauwels P., Sailer V., Gosney J., Miljkovic D., et al., "International real-world study of DLL3 expression in patients with small cell lung cancer", LUNG CANCER, cilt.147, ss.237-243, 2020 | |
dc.identifier.issn | 0169-5002 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_7e8fa60c-c997-4dae-b484-697645a305c2 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/3657 | |
dc.identifier.uri | https://doi.org/10.1016/j.lungcan.2020.07.026 | |
dc.description.abstract | Objectives: Expression of the Notch-family ligand delta-like protein 3 (DLL3), a potential therapeutic target in small cell lung cancer (SCLC), has not been assessed in the real-world setting. To identify the real-world utility of DLL3 as an SCLC therapeutic target, we performed the largest retrospective international noninterventional study to date to evaluate DLL3 prevalence in SCLC patients. | |
dc.language.iso | eng | |
dc.subject | Onkoloji | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | ONKOLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | SOLUNUM SİSTEMİ | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Göğüs Hastalıkları ve Allerji | |
dc.subject | İç Hastalıkları | |
dc.title | International real-world study of DLL3 expression in patients with small cell lung cancer | |
dc.type | Makale | |
dc.relation.journal | LUNG CANCER | |
dc.contributor.department | Hosp Univ Fdn Jimenez Diaz CIBERONC , , | |
dc.identifier.volume | 147 | |
dc.identifier.startpage | 237 | |
dc.identifier.endpage | 243 | |
dc.contributor.firstauthorID | 2286769 | |